Recombinant human erythropoietin (Hanyang University Seoul Hospital)
N/A
Report date: 2022/08/30 20:00:42
Base Information
Drug NameRecombinant human erythropoietin (Hanyang University Seoul Hospital)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanyang UniversityHanyang University Seoul Hospital
China Registration ClassN/A
Develop Information
Active CompaniesHanyang University Seoul Hospital
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A